Organigram to Acquire Aurora in C$561 Million Cannabis Deal
Organigram Global agreed to acquire Aurora Cannabis in a transaction valued at approximately C$561 million, announced November 3. Aurora holders can elect C$7.80 per share in cash, Organigram shares, or a combination, while the companies forecast more than C$50 million in annual savings. Aurora scheduled a shareholder vote for December 23, with closing expected in January 2027 if approvals are obtained.
Why it matters
The deal would combine Organigram’s Canadian recreational business with Aurora’s international medical platform. If approved, Aurora holders are expected to own approximately 35% of the combined company’s economic interests and 42% of its voting rights.
Key facts
- 1Aurora shareholders may choose C$7.80 in cash, 5.8626 Organigram shares, or C$3.75 in cash plus 3.0431 Organigram shares for each Aurora share. pulse2.com
- 2Aurora’s special shareholder meeting is scheduled for December 23, with November 18 as the record date. themarijuanaherald.com
- 3The acquisition requires at least two-thirds approval from votes cast by Aurora shareholders, along with additional shareholder, court and regulatory approvals. themarijuanaherald.com
- 4Aurora and Organigram expect more than C$50 million in annual operating benefits and cost savings from the combination. themarijuanaherald.com
- 5British American Tobacco’s subsidiary BT DE Investments agreed to invest approximately C$187.5 million in Organigram through a concurrent private placement. pulse2.com
- 6The combined company is expected to operate five EU-GMP-certified production and distribution facilities. legaldesire.com
Summary written by AlphAI AI Desk from 3 of 3 sources. Not investment advice. Figures are as stated by the linked sources.